Stem cells tested to heal COVID-Damaged lungs
NCT ID NCT05491681
Summary
This early-stage study aimed to test the safety of stem cell therapy for patients recovering from severe COVID-19 lung damage (ARDS). The treatment involved giving patients stem cells from donors to help reduce inflammation and promote healing. The study was withdrawn before any participants were enrolled.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ARDS, HUMAN are added.
By submitting, you agree to our Terms of use
Conditions
Explore the condition pages connected to this study.